Optimization of the method of RNA isolation from paraffin blocks to assess gene expression in breast cancer

Polish Journal of Pathology

Volumn 59, Issue 2, 2008, Pages 85-91

  Jarzab M ^a   Rozanowski P ^b,c   Kowalska, M ^a   Zebracka, J ^a   Rudnicka, L ^b   Stobiecka, E ^a   Jarzab B ^a   Stachura, J ^b   Pawlega J ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN;

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER PATIENT; CANCER SURGERY; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

ADENOCARCINOMA; BREAST NEOPLASMS; FEMALE; FIXATIVES; FORMALDEHYDE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PARAFFIN EMBEDDING; PROGNOSIS; REAGENT KITS, DIAGNOSTIC; RNA, NEOPLASM; SPECIMEN HANDLING;

EID: 47749085916     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. rd edition, MD, Armitage JO, Niederhuber JE et al. Elsevier Churchill Livingstone, Philadelphia 2004, 2399-2401.
2. Antonov J, Goldstein DR, Oberli A et al: Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 2005, 85, 8, 1040-1050.
3. Ayers M, Symmans WF, Stec J et al: Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and 5-fiuorouracil, doxorubicin, and cyclophos-phamide chemotherapy in breast cancer. J Clin Oncol 2004, 22, 2284-2293.
4. Balogh GA, Heulings R, Mailo D et al: Methodological approach to study the genomic profile of the human breast. Int J Oncol 2007, 31, 253-260.
5. Bonin S, Petrera F Rosai J et al: DNA and RNA obtained from Bouin's fixed tissues. J Clin Pathol 2005, 58, 313-316.
6. Chang JC, Makris A, Gutierrez MC et al: Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients. Breast Cancer Res Treat. 2007, 28, (Epub ahead of print).
7. Clark-Langone KM, Wu JY, Sangli C et al: Biomarker discovery for colon cancer using a 761 gene RT-PCR assay. BMC Genomics 2007, 15, 279.
8. Cobleigh MA, Tabesh B, Bitterman P et al: Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes. Clin Cancer Res 2005, 11, 8623-8631.
9. Cronin M, Pho M, Dutta D et al: Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol 2004, 164, 35-42.
10. Cronin M, Sangli C, Liu ML et al: Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer. Clin Chem 2007, 53, 1084-1091.
11. Dedhia P, Tarale S, Dhongde G et al: Evaluation of DNA extraction methods and real time PCR optimization on formalin-fixed paraffin-embedded tissues. Asian Pac J Cancer Prev 2007, 8, 55-59.
12. Delfour C, Roger P, Bret C et al: RCL2, a new fixative, preserves morphology and nucleic acid integrity in paraffin-embedded breast carcinoma and microdissected breast tumor cells. J Mol Diagn 2006, 8, 157-169.
13. Espinosa E, Vara JA, Redondo A et al: Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study. J Clin Oncol 2005, 23, 7278-7285.
14. Esteban J, Beker J, Cronin M et al: Tumor gene expression and prognosis in breast cancer: multigene RT-PCR assay of paraffin-embedded tissue. Proc Am Soc Clin Oncol 2003, 22, 850 (abstr. 3416).
15. Gjerdrum LM, Sorensen BS, Kjeldsen E et al: Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis. J Mol Diagn 2004, 6, 42-51.
16. Harris L, Fritsche H, Mennel R et al: American Society of Clinical Oncology 2007 Update of Recommendation for the Use of Tumor Markers in Breast Cancer. J Clin Oncol 2007, 25, 5287-5312.
17. rd edition, MD, Armitage JO, Niederhuber JE et al. Elsevier Churchill Livingstone, Philadelphia 2004, 325-327.
18. Loudig O, Milova E, Brandwein-Gensler M et al: Molecular restoration of archived transcriptional profiles by complementary-template reverse-transcription (CT-RT). Nucleic Acids Res 2007, 35, 94.
19. Mina L, Soule SE, Badve S et al: Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue. Breast Cancer Res Treat 2007, 103, 197-208.
20. Paik S, Shank S, Tang G et al: A multigene assay to predict recurrence of tamoxifen-treated node-negative breast cancer. N Engl J Med 2004, 351, 2817-2826.
21. Paik S, Tang G, Shak S et al: Gene expression and benefits of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006, 24, 3726-3734.
22. Perou CM, Sorlie T Eisen MB et al: Molecular portraits of human breast tumours. Nature 2000, 406, 747-752.
23. Smith RA, Lea RA, Weinstein SR et al: Detection of mRNA levels for the estrogen alpha, estrogen beta and androgen nuclear receptor genes in archival breast cancer tissue. Cancer Lett 2006, 237, 248-255.
24. Veer LJ, Dai H, Vijver MJ et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415, 530-536.
25. Vijver MJ, He YD, Veer LJ et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347, 1999-2009.
26. Workman P, Johnston P: Genomic profiling of cancer: What next? J Clin Oncol 2005, 23, 7253-7256.